98 related articles for article (PubMed ID: 10471782)
1. Enhanced anti-HIV-1 activity of CC-chemokine LD78beta, a non-allelic variant of MIP-1alpha/LD78alpha.
Xin X; Shioda T; Kato A; Liu H; Sakai Y; Nagai Y
FEBS Lett; 1999 Aug; 457(2):219-22. PubMed ID: 10471782
[TBL] [Abstract][Full Text] [Related]
2. The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.
Aquaro S; Menten P; Struyf S; Proost P; Van Damme J; De Clercq E; Schols D
J Virol; 2001 May; 75(9):4402-6. PubMed ID: 11287590
[TBL] [Abstract][Full Text] [Related]
3. LD78beta, a non-allelic variant of human MIP-1alpha (LD78alpha), has enhanced receptor interactions and potent HIV suppressive activity.
Nibbs RJ; Yang J; Landau NR; Mao JH; Graham GJ
J Biol Chem; 1999 Jun; 274(25):17478-83. PubMed ID: 10364178
[TBL] [Abstract][Full Text] [Related]
4. The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine.
Menten P; Struyf S; Schutyser E; Wuyts A; De Clercq E; Schols D; Proost P; Van Damme J
J Clin Invest; 1999 Aug; 104(4):R1-5. PubMed ID: 10449444
[TBL] [Abstract][Full Text] [Related]
5. Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils.
Struyf S; Menten P; Lenaerts JP; Put W; D'Haese A; De Clercq E; Schols D; Proost P; Van Damme J
Eur J Immunol; 2001 Jul; 31(7):2170-8. PubMed ID: 11449371
[TBL] [Abstract][Full Text] [Related]
6. Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist.
Proost P; Menten P; Struyf S; Schutyser E; De Meester I; Van Damme J
Blood; 2000 Sep; 96(5):1674-80. PubMed ID: 10961862
[TBL] [Abstract][Full Text] [Related]
7. Proteolysis of macrophage inflammatory protein-1alpha isoforms LD78beta and LD78alpha by neutrophil-derived serine proteases.
Ryu OH; Choi SJ; Firatli E; Choi SW; Hart PS; Shen RF; Wang G; Wu WW; Hart TC
J Biol Chem; 2005 Apr; 280(17):17415-21. PubMed ID: 15728180
[TBL] [Abstract][Full Text] [Related]
8. Macrophage inflammatory protein-1.
Menten P; Wuyts A; Van Damme J
Cytokine Growth Factor Rev; 2002 Dec; 13(6):455-81. PubMed ID: 12401480
[TBL] [Abstract][Full Text] [Related]
9. Chemokine PARC gene (SCYA18) generated by fusion of two MIP-1alpha/LD78alpha-like genes.
Tasaki Y; Fukuda S; Iio M; Miura R; Imai T; Sugano S; Yoshie O; Hughes AL; Nomiyama H
Genomics; 1999 Feb; 55(3):353-7. PubMed ID: 10049593
[TBL] [Abstract][Full Text] [Related]
10. Identification of amino acid residues critical for LD78beta, a variant of human macrophage inflammatory protein-1alpha, binding to CCR5 and inhibition of R5 human immunodeficiency virus type 1 replication.
Miyakawa T; Obaru K; Maeda K; Harada S; Mitsuya H
J Biol Chem; 2002 Feb; 277(7):4649-55. PubMed ID: 11734558
[TBL] [Abstract][Full Text] [Related]
11. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1.
Oberlin E; Amara A; Bachelerie F; Bessia C; Virelizier JL; Arenzana-Seisdedos F; Schwartz O; Heard JM; Clark-Lewis I; Legler DF; Loetscher M; Baggiolini M; Moser B
Nature; 1996 Aug; 382(6594):833-5. PubMed ID: 8752281
[TBL] [Abstract][Full Text] [Related]
12. Beta-chemokines that inhibit HIV-1 infection of human macrophages stimulate uptake and promote destruction of Trypanosoma cruzi by human macrophages.
Lima MF; Zhang Y; Villalta F
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1067-76. PubMed ID: 9449540
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HIV type 1 BaL replication by MIP-1alpha, MIP-1beta, and RANTES in macrophages.
Capobianchi MR; Abbate I; Antonelli G; Turriziani O; Dolei A; Dianzani F
AIDS Res Hum Retroviruses; 1998 Feb; 14(3):233-40. PubMed ID: 9491913
[TBL] [Abstract][Full Text] [Related]
14. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines.
Margolis LB; Glushakova S; Grivel JC; Murphy PM
J Clin Invest; 1998 May; 101(9):1876-80. PubMed ID: 9576751
[TBL] [Abstract][Full Text] [Related]
15. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
[TBL] [Abstract][Full Text] [Related]
16. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.
Alkhatib G; Combadiere C; Broder CC; Feng Y; Kennedy PE; Murphy PM; Berger EA
Science; 1996 Jun; 272(5270):1955-8. PubMed ID: 8658171
[TBL] [Abstract][Full Text] [Related]
17. Difference in susceptibility to CC-chemokines among HIV-1 isolates.
Gao M; Tsuchie H; Jin TQ; Zhang J; Detorio MA; Hossain MM; Taniguchi K; Kurimura T
Int J STD AIDS; 1998 Aug; 9(8):471-5. PubMed ID: 9702596
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide regulates MIP-1alpha expression in primary macrophages and T lymphocytes: implications for anti-HIV-1 response.
Sherry B; Schmidtmayerova H; Zybarth G; Dubrovsky L; Raabe T; Bukrinsky M
Mol Med; 2000 Jun; 6(6):542-9. PubMed ID: 10972089
[TBL] [Abstract][Full Text] [Related]
19. Macrophage inflammatory protein-1alpha (MIP-1alpha) expression plasmid enhances DNA vaccine-induced immune response against HIV-1.
Lu Y; Xin KQ; Hamajima K; Tsuji T; Aoki I; Yang J; Sasaki S; Fukushima J; Yoshimura T; Toda S; Okada E; Okuda K
Clin Exp Immunol; 1999 Feb; 115(2):335-41. PubMed ID: 9933462
[TBL] [Abstract][Full Text] [Related]
20. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.
Maeda Y; Foda M; Matsushita S; Harada S
J Virol; 2000 Feb; 74(4):1787-93. PubMed ID: 10644351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
